Doc Testimony Over Discontinuing NuvaRing Axed From MDL

Law360, New York (March 22, 2013, 5:48 PM EDT) -- A Missouri judge on Friday rejected a doctor's testimony arguing the contraceptive NuvaRing should be pulled from the market, but refused to exclude future testimony to that effect in the sprawling product liability multidistrict litigation against a Merck & Co. Inc. subsidiary.

Judge Rodney Sippel agreed with NuvaRing maker Organon USA Inc. that a doctor’s testimony — in which he asserted that the product should be taken off the market because of an increased risk of dangerous blood clots — was based on his own personal...
To view the full article, register now.




Case Information

Case Title

In Re: Nuvaring Products Liability Litigation

Case Number



Missouri Eastern

Nature of Suit

Personal Inj. Prod. Liability


Rodney W. Sippel

Date Filed

August 22, 2008

Law Firms


UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.